VanEck Associates
APLS icon

VanEck Associates’s Apellis Pharmaceuticals APLS Stock Holding History

VanEck Associates’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,601
Closed -$403K – 1396
2023
Q3 		$403K Buy
+10,601
New +$403K ﹤0.01% 1065